Loading...
Chemical structure of BAY1082439

GC62164

BAY1082439

Also known as N-[8-[(2R)-2-hydroxy-3-morpholin-4-ylpropoxy]-7-methoxy-2,3-dihydro-1H-imidazo[1,2-c]quinazolin-5-ylidene]-2-methylpyridine-3-carboxamide

BAY1082439 is an orally bioavailable, selective PI3Kα/β/δ inhibitor· BAY1082439 also inhibits mutated forms of PIK3CA· BAY1082439 is highly effective in inhibiting Pten-null prostate cancer growth

ChemicalCAS1375469-38-7MW494.54FormulaC25H30N6O5
CAS number
1375469-38-7
Molecular weight
494.54
Formula
C25H30N6O5
Solubility
DMSO ： 5 mg/mL (10·11 mM; ultrasonic and adjust pH to 5 with HCl)
InChIKey
QJTLLKKDFGPDPF-QGZVFWFLSA-N
Catalogue number
GC62164
Brand
GLPBIO
Computed properties PubChem CID 135905473 · XLogP 0.8 · TPSA 121 Ų · H-bond donors 2
XLogP
0.8
TPSA
121 Ų
H-bond donors
2
H-bond acceptors
8
Rotatable bonds
7
Heavy atoms
36

SMILES CC1=C(C=CC=N1)C(=O)N=C2N=C3C(=C4N2CCN4)C=CC(=C3OC)OC[C@@H](CN5CCOCC5)O

Computed descriptors from PubChem (CID 135905473), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.